title: A patient with proximal myotonic myopathy and parkinsonism.
abstract: BACKGROUND
  There are two case reports of patients who had proximal myotonic myopathy (PROMM)/myotonic dystrophy (DM) Type 1 and parkinsonism. The combination of myotonic myopathy and parkinsonism is so rare that it may appear to be just a coincidence. However, previous neuropathological examinations of patients who had myotonic dystrophy showed that there were intracytoplasmic inclusion bodies in the nigra and striatum, which raises the possibility that myotonic myopathy may be associated with parkinsonism. In this report we describe a patient with PROMM and a clinically definite parkinsonism to highlight this possibility.
  
  
  METHODS
  A 65-year-old man developed proximal muscle weakness, myotonia and atrophy around the age of 55 and was diagnosed as having PROMM at the age of 62. Needle electromyography and muscle biopsy supported the diagnosis. A gene study of the DM Type 1 showed a normal CTG repeat length. At age 63, he developed rest tremor, bradykinesia, hypomimia, stooped posture, and gait disturbance. The postural instability worsened rapidly. The tremor and rigidity were much worse in his right side, where myotonia was more severe. Levodopa therapy was only partially effective.
  
  
  CONCLUSIONS
  This is a case report of a patient with PROMM that shows an association with a rapidly progressive form of parkinsonism. We suggest that this may be a novel form of a neurodegenerative disorder, which we name 'Parkinsonism-Myotonic Myopathy-Complex'.
authors.affiliation: Department of Neurology and Clinical Research Institute, Seoul National University Hospital, Korea.
authors.forename: Kon
authors.initials: K
authors.lastname: Chu
authors.forename: Jin-Whan
authors.initials: JW
authors.lastname: Cho
authors.forename: Eun-Chol
authors.initials: EC
authors.lastname: Song
authors.forename: Beom S
authors.initials: BS
authors.lastname: Jeon
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D009132:Muscles / Q000503:physiopathology; D020967:Myotonic Disorders / Q000150:complications* / Q000473:pathology / Q000503:physiopathology*; D020734:Parkinsonian Disorders / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa